Peragine N, De Propris MS, Intoppa S, Milani ML, et al. Early CD49d downmodulation in chronic lymphocytic leukemia patients treated front-line with ibrutinib plus rituximab predicts long-term response. Leuk Lymphoma 2022 Aug 1:1-5. doi: 10.1080/10428194.2022.2105324.
PMID: 35913400